Occupe actuellement des postes chez DexCom Inc, AxoGen Inc and Alphatec Holdings Inc
Position | Company | Period |
---|---|---|
Chief Financial Officer, Chief Operating Officer | DexCom Inc | 1 octobre 2019 - |
Director | AxoGen Inc | 15 mai 2019 - |
Independent Director | Alphatec Holdings Inc | 1 octobre 2017 - |
Chief Financial Officer, Executive Vice President | DexCom Inc | 1 septembre 2017 - 1 octobre 2019 |
Chief Financial Officer, Executive Vice President Head of Strategy and Corporate Integrity | NuVasive Inc | 1 août 2014 - 25 août 2017 |
Executive Vice President - Finance and Investor Relations | NuVasive Inc | 1 février 2014 - 1 août 2014 |
Rechercher
Date de notification | Date de transaction | A/V Type de transaction |
Nb. d'actions Prix Valeur |
Nombre d'actions | Prix | Valeur totale | Détails | |
---|---|---|---|---|---|---|---|---|
2024-03-08 | 2024-03-07 |
Alphatec Holdings Inc
(ATEC)
|
A Achat |
20 000
+3.6%
12,83256 600 USD |
20 000 +3.6% | 12,83 | 256 600 USD | |
2024-03-01 | 2024-02-29 |
iRhythm Technologies Inc
(IRTC)
|
V Vente |
24 701
-12.1%
121,963 012 534 USD |
24 701 -12.1% | 121,96 | 3 012 534 USD | |
2022-11-04 | 2022-11-02 |
iRhythm Technologies Inc
(IRTC)
|
V Vente |
12 415
-12.2%
122,501 520 838 USD |
12 415 -12.2% | 122,50 | 1 520 838 USD | |
2022-11-04 | 2022-11-02 |
iRhythm Technologies Inc
(IRTC)
|
V Vente |
284
-0.3%
118,1733 560 USD |
284 -0.3% | 118,17 | 33 560 USD | |
2021-03-12 | 2021-03-10 |
DexCom Inc
(DXCM)
|
V Vente |
6 509
-12.6%
362,222 357 688 USD |
6 509 -12.6% | 362,22 | 2 357 688 USD | |
2020-09-11 | 2020-09-10 |
DexCom Inc
(DXCM)
|
VP Vente planifiée |
171
-0.4%
405,3369 311 USD |
171 -0.4% | 405,33 | 69 311 USD | |
2020-09-11 | 2020-09-10 |
DexCom Inc
(DXCM)
|
VP Vente planifiée |
272
-0.6%
403,87109 854 USD |
272 -0.6% | 403,87 | 109 854 USD | |
2020-09-11 | 2020-09-10 |
DexCom Inc
(DXCM)
|
VP Vente planifiée |
2 159
-4.6%
402,72869 471 USD |
2 159 -4.6% | 402,72 | 869 471 USD | |
2020-09-11 | 2020-09-10 |
DexCom Inc
(DXCM)
|
VP Vente planifiée |
3 157
-6.3%
401,791 268 455 USD |
3 157 -6.3% | 401,79 | 1 268 455 USD | |
2020-09-11 | 2020-09-10 |
DexCom Inc
(DXCM)
|
VP Vente planifiée |
3 017
-5.7%
399,911 206 536 USD |
3 017 -5.7% | 399,91 | 1 206 536 USD | |
2020-09-11 | 2020-09-10 |
DexCom Inc
(DXCM)
|
VP Vente planifiée |
1 594
-2.9%
398,98635 978 USD |
1 594 -2.9% | 398,98 | 635 978 USD | |
2020-09-11 | 2020-09-10 |
DexCom Inc
(DXCM)
|
VP Vente planifiée |
1 300
-2.3%
397,76517 090 USD |
1 300 -2.3% | 397,76 | 517 090 USD | |
2020-09-11 | 2020-09-10 |
DexCom Inc
(DXCM)
|
VP Vente planifiée |
523
-0.9%
397,03207 647 USD |
523 -0.9% | 397,03 | 207 647 USD | |
2020-09-11 | 2020-09-09 |
DexCom Inc
(DXCM)
|
V Vente |
1 579
-2.7%
398,30628 919 USD |
1 579 -2.7% | 398,30 | 628 919 USD | |
2020-09-11 | 2020-09-09 |
DexCom Inc
(DXCM)
|
V Vente |
3 297
-5.4%
398,301 313 202 USD |
3 297 -5.4% | 398,30 | 1 313 202 USD | |
2020-09-11 | 2020-09-09 |
DexCom Inc
(DXCM)
|
V Vente |
8 010
-11.6%
398,303 190 399 USD |
8 010 -11.6% | 398,30 | 3 190 399 USD | |
2020-03-13 | 2020-03-12 |
DexCom Inc
(DXCM)
|
VP Vente planifiée |
100
-0.1%
244,7824 478 USD |
100 -0.1% | 244,78 | 24 478 USD | |
2020-03-13 | 2020-03-12 |
DexCom Inc
(DXCM)
|
VP Vente planifiée |
400
-0.6%
244,0197 604 USD |
400 -0.6% | 244,01 | 97 604 USD | |
2020-03-13 | 2020-03-12 |
DexCom Inc
(DXCM)
|
VP Vente planifiée |
500
-0.7%
241,06120 532 USD |
500 -0.7% | 241,06 | 120 532 USD | |
2020-03-13 | 2020-03-12 |
DexCom Inc
(DXCM)
|
VP Vente planifiée |
1 100
-1.5%
239,63263 596 USD |
1 100 -1.5% | 239,63 | 263 596 USD | |
2020-03-13 | 2020-03-12 |
DexCom Inc
(DXCM)
|
VP Vente planifiée |
600
-0.8%
238,29142 972 USD |
600 -0.8% | 238,29 | 142 972 USD | |
2020-03-13 | 2020-03-12 |
DexCom Inc
(DXCM)
|
VP Vente planifiée |
641
-0.9%
237,10151 980 USD |
641 -0.9% | 237,10 | 151 980 USD | |
2020-03-13 | 2020-03-12 |
DexCom Inc
(DXCM)
|
VP Vente planifiée |
472
-0.6%
235,90111 344 USD |
472 -0.6% | 235,90 | 111 344 USD | |
2020-03-13 | 2020-03-12 |
DexCom Inc
(DXCM)
|
VP Vente planifiée |
300
-0.4%
234,2370 270 USD |
300 -0.4% | 234,23 | 70 270 USD | |
2020-03-13 | 2020-03-12 |
DexCom Inc
(DXCM)
|
VP Vente planifiée |
200
-0.3%
232,0046 400 USD |
200 -0.3% | 232,00 | 46 400 USD | |
2020-03-13 | 2020-03-12 |
DexCom Inc
(DXCM)
|
VP Vente planifiée |
200
-0.3%
228,8645 772 USD |
200 -0.3% | 228,86 | 45 772 USD | |
2020-03-13 | 2020-03-12 |
DexCom Inc
(DXCM)
|
VP Vente planifiée |
400
-0.5%
227,5691 025 USD |
400 -0.5% | 227,56 | 91 025 USD | |
2020-03-13 | 2020-03-12 |
DexCom Inc
(DXCM)
|
VP Vente planifiée |
457
-0.6%
223,62102 196 USD |
457 -0.6% | 223,62 | 102 196 USD | |
2020-03-13 | 2020-03-12 |
DexCom Inc
(DXCM)
|
V Vente |
200
-0.3%
220,5044 100 USD |
200 -0.3% | 220,50 | 44 100 USD | |
2020-03-13 | 2020-03-12 |
DexCom Inc
(DXCM)
|
VP Vente planifiée |
200
-0.3%
219,3743 873 USD |
200 -0.3% | 219,37 | 43 873 USD | |
2020-03-13 | 2020-03-12 |
DexCom Inc
(DXCM)
|
VP Vente planifiée |
583
-0.8%
218,84127 582 USD |
583 -0.8% | 218,84 | 127 582 USD | |
2020-03-13 | 2020-03-11 |
DexCom Inc
(DXCM)
|
V Vente |
5 963
-7.3%
265,431 582 735 USD |
5 963 -7.3% | 265,43 | 1 582 735 USD | |
2020-03-13 | 2020-03-11 |
DexCom Inc
(DXCM)
|
V Vente |
129
-0.2%
251,0332 383 USD |
129 -0.2% | 251,03 | 32 383 USD | |
2020-03-13 | 2020-03-11 |
DexCom Inc
(DXCM)
|
V Vente |
116
-0.1%
246,6128 607 USD |
116 -0.1% | 246,61 | 28 607 USD | |
2020-03-10 | 2020-03-09 |
DexCom Inc
(DXCM)
|
VP Vente planifiée |
891
-1.1%
261,00232 551 USD |
891 -1.1% | 261,00 | 232 551 USD | |
2019-09-12 | 2019-09-10 |
DexCom Inc
(DXCM)
|
VP Vente planifiée |
600
-0.9%
144,5786 742 USD |
600 -0.9% | 144,57 | 86 742 USD | |
2019-09-12 | 2019-09-10 |
DexCom Inc
(DXCM)
|
VP Vente planifiée |
406
-0.6%
143,5758 288 USD |
406 -0.6% | 143,57 | 58 288 USD | |
2019-09-12 | 2019-09-10 |
DexCom Inc
(DXCM)
|
VP Vente planifiée |
1 289
-1.8%
142,16183 247 USD |
1 289 -1.8% | 142,16 | 183 247 USD | |
2019-09-12 | 2019-09-10 |
DexCom Inc
(DXCM)
|
VP Vente planifiée |
3 725
-4.9%
141,62527 517 USD |
3 725 -4.9% | 141,62 | 527 517 USD | |
2019-09-12 | 2019-09-10 |
DexCom Inc
(DXCM)
|
VP Vente planifiée |
2 500
-3.2%
140,47351 181 USD |
2 500 -3.2% | 140,47 | 351 181 USD | |
2019-09-12 | 2019-09-10 |
DexCom Inc
(DXCM)
|
VP Vente planifiée |
1 800
-2.2%
139,29250 716 USD |
1 800 -2.2% | 139,29 | 250 716 USD | |
2019-09-11 | 2019-09-09 |
DexCom Inc
(DXCM)
|
V Vente |
11 049
-12.1%
150,111 658 578 USD |
11 049 -12.1% | 150,11 | 1 658 578 USD | |
2019-09-11 | 2019-09-09 |
DexCom Inc
(DXCM)
|
V Vente |
637
-0.7%
145,4592 654 USD |
637 -0.7% | 145,45 | 92 654 USD | |
2019-05-30 | 2019-05-29 |
DexCom Inc
(DXCM)
|
VP Vente planifiée |
3 376
-3.5%
119,30402 762 USD |
3 376 -3.5% | 119,30 | 402 762 USD | |
2019-05-30 | 2019-05-29 |
DexCom Inc
(DXCM)
|
VP Vente planifiée |
5 498
-5.5%
118,73652 765 USD |
5 498 -5.5% | 118,73 | 652 765 USD | |
2019-03-13 | 2019-03-12 |
DexCom Inc
(DXCM)
|
V Vente |
5 358
-5.1%
142,79765 081 USD |
5 358 -5.1% | 142,79 | 765 081 USD | |
2018-09-12 | 2018-09-10 |
DexCom Inc
(DXCM)
|
V Vente |
7 149
-7.0%
143,761 027 706 USD |
7 149 -7.0% | 143,76 | 1 027 706 USD |